JP2021535170A5 - - Google Patents

Info

Publication number
JP2021535170A5
JP2021535170A5 JP2021511602A JP2021511602A JP2021535170A5 JP 2021535170 A5 JP2021535170 A5 JP 2021535170A5 JP 2021511602 A JP2021511602 A JP 2021511602A JP 2021511602 A JP2021511602 A JP 2021511602A JP 2021535170 A5 JP2021535170 A5 JP 2021535170A5
Authority
JP
Japan
Prior art keywords
vol
approximately
composition
composition according
amount
Prior art date
Application number
JP2021511602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535170A (ja
JP7534284B2 (ja
JPWO2020047422A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/049084 external-priority patent/WO2020047422A1/en
Publication of JP2021535170A publication Critical patent/JP2021535170A/ja
Publication of JP2021535170A5 publication Critical patent/JP2021535170A5/ja
Publication of JPWO2020047422A5 publication Critical patent/JPWO2020047422A5/ja
Priority to JP2024125762A priority Critical patent/JP2024170397A/ja
Application granted granted Critical
Publication of JP7534284B2 publication Critical patent/JP7534284B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021511602A 2018-08-31 2019-08-30 薬物送達のための相乗的な透過促進剤を伴う組成物 Active JP7534284B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024125762A JP2024170397A (ja) 2018-08-31 2024-08-01 薬物送達のための相乗的な透過促進剤を伴う組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862726058P 2018-08-31 2018-08-31
US62/726,058 2018-08-31
US201962814161P 2019-03-05 2019-03-05
US62/814,161 2019-03-05
PCT/US2019/049084 WO2020047422A1 (en) 2018-08-31 2019-08-30 Compositions with synergistic permeation enhancers for drug delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024125762A Division JP2024170397A (ja) 2018-08-31 2024-08-01 薬物送達のための相乗的な透過促進剤を伴う組成物

Publications (4)

Publication Number Publication Date
JP2021535170A JP2021535170A (ja) 2021-12-16
JP2021535170A5 true JP2021535170A5 (https=) 2022-08-22
JPWO2020047422A5 JPWO2020047422A5 (https=) 2022-08-22
JP7534284B2 JP7534284B2 (ja) 2024-08-14

Family

ID=69642825

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021511602A Active JP7534284B2 (ja) 2018-08-31 2019-08-30 薬物送達のための相乗的な透過促進剤を伴う組成物
JP2024125762A Pending JP2024170397A (ja) 2018-08-31 2024-08-01 薬物送達のための相乗的な透過促進剤を伴う組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024125762A Pending JP2024170397A (ja) 2018-08-31 2024-08-01 薬物送達のための相乗的な透過促進剤を伴う組成物

Country Status (5)

Country Link
US (1) US20210322396A1 (https=)
EP (1) EP3843785A4 (https=)
JP (2) JP7534284B2 (https=)
CA (1) CA3110566A1 (https=)
WO (1) WO2020047422A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20180128A (es) 2015-08-05 2018-04-24 Childrens Medical Center Composiciones con potenciadores de permeación para suministro de fármacos
CN118121541B (zh) * 2024-03-14 2025-09-16 江西省保灵动物保健品有限公司 一种盐酸特比萘芬喷雾剂的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051290A2 (en) * 1997-05-16 1998-11-19 Children's Medical Center Corporation Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
US8658699B2 (en) * 2008-05-19 2014-02-25 Massachusetts Institute Of Technology Chemical permeation enhancers enhance nerve blockade by toxins
US9505737B2 (en) * 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
CR20180128A (es) 2015-08-05 2018-04-24 Childrens Medical Center Composiciones con potenciadores de permeación para suministro de fármacos

Similar Documents

Publication Publication Date Title
JP5714512B2 (ja) 哺乳動物の内耳及び外耳の感染症の治療に有用な耳科用組成物
JP6539444B2 (ja) 安定なポビドンヨード組成物
JP2018522905A5 (https=)
JP2019194191A5 (https=)
JP2014516954A5 (https=)
CN102316863B (zh) 5-苄基氨基水杨酸衍生物或其盐的医药用途
CA2465132A1 (en) Vaginally administered anti-dysrhythmic agents for treating pelvic pain
JP2019529541A5 (https=)
JP2021535170A5 (https=)
JP2021073257A5 (https=)
JP2020524689A5 (https=)
PH12022551798A1 (en) Use of benzoate compound in treatment of sars-cov-2 infection
JP2020536048A5 (https=)
NZ753781A (en) Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
WO2018217139A4 (ru) Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний
TW200902093A (en) N-halogenated amino acid formulations
JPWO2020047422A5 (https=)
JPH11228387A (ja) ヨード系殺菌剤を含有する薬用組成物
EA201991188A1 (ru) Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний
JP2018532807A5 (https=)
AU2020201113A1 (en) Antimicrobial compositions and methods of use
TW200902092A (en) Aliphatic acid-containing N-halogenated amino acid formulations
JP2008519848A5 (https=)
JP5669145B2 (ja) 表面麻酔剤
JP2003523995A5 (https=)